Results 181 to 190 of about 7,662 (208)

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

open access: gold, 2013
Jean-Michel Dogné   +6 more
openalex   +2 more sources

Multifunctional nanoagonist enhances photodynamic therapy-driven in situ cancer vaccination by inhibiting tumor thrombosis. [PDF]

open access: yesJ Nanobiotechnology
Liu C   +9 more
europepmc   +1 more source

Scientific coformer screening, preparation and evaluation of Dabigatran Etexilate Mesylate Cocrystal

open access: bronze, 2018
Shankar Pol   +4 more
openalex   +1 more source

Hemopericardium and Cardiac Tamponade in a Patient Treated with Dabigatran Etexilate. [PDF]

open access: yesKorean Circ J, 2016
Kızılırmak F   +5 more
europepmc   +1 more source

Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. [PDF]

open access: yesRes Pract Thromb Haemost, 2018
Albisetti M   +7 more
europepmc   +1 more source

Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender. [PDF]

open access: yesBiochem Pharmacol, 2016
Shi J   +6 more
europepmc   +1 more source

The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis. [PDF]

open access: yesHum Genomics
Aldiban W   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy